31LB
National HIV Prevalence and BED HIV Incidence Estimates: South Africa 2005
Thomas Rehle*1, A Puren2, K Zuma1, V Pillay1, P Dana1, and O Shisana1
1Human Sci Res Council, Cape Town, South Africa and 2Natl Inst for Communicable Diseases, Johannesburg, South Africa
Background: The complexities and limitations of
epidemiological approaches to measure HIV incidence argue strongly for a
laboratory-based method that can distinguish recent from established long-term
HIV infections. The 2005 South African national household survey on HIV,
behavior, and communication included HIV incidence testing, which for the first
time allowed a joint analysis of HIV prevalence,
HIV incidence, and HIV-associated risk factors.
Methods: Of 23,275 individuals, aged 2 years and older, who participated
in the survey, 15,851 agreed to be tested for HIV. Linked anonymous testing,
i.e. the HIV test result can be linked to demographic and behavioral data
without revealing the identity of the tested individual, was performed using
dried blood spot (DBS) specimens. The detection of recent infections in
confirmed HIV+ samples was performed with the BED capture enzyme
immunoassay. An HIV+ specimen with a normalized optical
density value of ≤0.8 was considered to be a specimen of recent HIV infection, otherwise, the specimen was classified as
long-term infection. Annualized BED HIV incidence calculation applied a
window period of 180 days for HIV subtype C specimens and took into account the
complex survey design.
Results: The national HIV prevalence in the
population of people 2 years and older is estimated to be 10.8%, with a higher
prevalence in women (13.3%) than in men (8.2%). HIV prevalence
increases among young females from 9.4% in the 15 to 19 age group to 33.3% in
the 25 to 29 age group. In males, the increase in HIV prevalence is more
protracted, and peaks at a lower level than for females, 23.3% in age groups 30
to 34 and 35 to 39. Especially
alarming is the incidence rate among young females. Females aged 15 to 24 years
have an 8 times higher HIV incidence than males, 6.5% compared to 0.8%, and
account for 87% of the recent HIV infections in this age group. Our incidence
analysis also suggests an increased risk of HIV acquisition during pregnancy.
Among African women aged 15 to 49 years, and who were pregnant in the last 24
months, an HIV incidence of 7.9% was found, the highest incidence rate of all
analyzed sub-populations in our survey.
Conclusions: The addition of HIV incidence testing to the
survey protocol enables a more precise and timely analysis of the current
HIV-transmission dynamics and a more relevant assessment of the effect of
prevention programs in South
Africa.
|